Triphenyl monomers suitable for microstructured optical films
US-9221743-B2 · Dec 29, 2015 · US
US9365534B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9365534-B2 |
| Application number | US-201414230267-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 31, 2014 |
| Priority date | Nov 19, 2009 |
| Publication date | Jun 14, 2016 |
| Grant date | Jun 14, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to arylated camphenes, processes for their preparation and uses thereof for the manufacture of medicaments for the treatment of diseases, disorders or conditions associated with, or benefiting from stimulation of CB2 receptors.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula wherein R j is selected from H, and —OR n wherein R n is selected form H, —COOR t , a straight or branched C 1 -C 5 alkyl optionally substituted by at least one group selected from —COOH, —NH 2 ; and R t is selected from H, C 1 -C 5 alkyl and —NH 2 ; and R m is selected from a straight or branched C 6 -C 12 alkyl, a straight or branched C 5 -C 9 alkoxy; each optionally substituted by at least one group selected from —COOH, —NH 2 . 2. A compound selected from the group consisting of: 3. A pharmaceutical composition comprising a compound according to claim 1 . 4. A pharmaceutical composition comprising a compound according to claim 2 .
Antineoplastic agents · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title
specific for metastasis · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.